Sanofi Says Dupixent Granted European Union Approval to Treat Chronic Obstructive Pulmonary Disease (Copd)
賽諾菲安萬特稱,歐盟已批准杜派克單抗用於治療慢性阻塞性肺疾病(COPD)
Sanofi Says Dupixent Granted European Union Approval to Treat Chronic Obstructive Pulmonary Disease (Copd)
賽諾菲安萬特稱,歐盟已批准杜派克單抗用於治療慢性阻塞性肺疾病(COPD)
譯文內容由第三人軟體翻譯。